Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 7, Issue 10, 2013, Pages

  Walsh, A J ^a   Weltman, M ^b   Burger, D ^c   Vivekanandarajah, S ^d   Connor, S ^d   Howlett, M ^e   Radford Smith, G ^e,f   Selby, W ^g   Veillard, A S ^h   Grimm, M C ⁱ   Travis, S P L ^c   Lawrance, I C ^j  

^a ST VINCENT S HOSPITAL   (Australia)

^b NEPEAN HOSPITAL   (Australia)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d LIVERPOOL HOSPITAL   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h UNIVERSITY OF SYDNEY   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

Implementing guidelines; Inflammatory bowel disease; Screening; Vaccination

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CHICKENPOX VACCINE; HEPATITIS B VACCINE; HEPATITIS C VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MERCAPTOPURINE; METHOTREXATE; PNEUMOCOCCUS VACCINE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; WART VIRUS VACCINE;

ARTICLE; AWARENESS; BLOOD SAMPLING; CHICKENPOX; ENTERITIS; FEMALE; FOLLOW UP; GASTROENTEROLOGIST; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PAPILLOMAVIRUS INFECTION; PATIENT COMPLIANCE; PATIENT EDUCATION; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SELF CONCEPT; STREPTOCOCCUS PNEUMONIAE; TELEPHONE INTERVIEW; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; ULCERATIVE COLITIS; UTERINE CERVIX CYTOLOGY; VACCINATION; WART VIRUS;

IMPLEMENTING GUIDELINES; INFLAMMATORY BOWEL DISEASE; SCREENING; VACCINATION;

ADULT; CHICKENPOX; FEMALE; GASTROENTEROLOGY; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INFLUENZA, HUMAN; MALE; MASS SCREENING; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PAPILLOMAVIRUS INFECTIONS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PNEUMOCOCCAL INFECTIONS; PRACTICE GUIDELINES AS TOPIC; RECORDS AS TOPIC; SELF REPORT; TUBERCULOSIS; VACCINATION;

EID: 84884162848     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.02.019     Document Type: Article

References (14)

1. Ramadas A.V., Gunesh S., Thomas G.A., Williams G.T., Hawthorne A.B. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010, 59(9):1200-1206.
2. Feagan B.G., Panaccione R., Sandborn W., D'Haens G.R., Schreiber S., Rutgeerts P.J., et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008, 135(5):1493-1499.
3. Toruner M., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Orenstein R., Sandborn W.J., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008, 134(4):929-936.
4. Lawrance I.C., Radford-Smith G.L., Bampton P.A., Andrews J.M., Tan P.K., Croft A., et al. Serious infective complications associated with anti-TNF therapy in inflammatory bowel disease: an Australian and New Zealand experience. J Gastroenterol Hepatol 2010, 25(11):1732-1738.
5. Andrisani G., Frasca D., Armuzzi A., et al. Response to 2009 vaccine for influenza A/H1N1 in patients with inflammatory bowel disease on anti TNFa therapy. J Crohns Colitis 2012, P159.
6. Dotan I., Mandelboim M., Shaharabani H., et al. Influenza A H1N1 vaccine is safe and effective in patients with inflammatory bowel disease with thiopurine and TNF-a blocker. J Crohns Colitis 2012, P259.
7. Chaparro M., Rodriguez-Nogueiras A., Menchen L.A., et al. Comparative study to evaluate the effectiveness of two different vaccination protocols against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients. J Crohns Colitis 2012, P233.
8. Fiorino G., Naccarto P., Szabo H., et al. Effect of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. J Crohns Colitis 2012, P201.
9. Rahier J.F., Ben-Horin S., Chowers Y., et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009, 3(2):47-91.
10. Grol R., Wensing M., Eccles M. Improving patient care: the implementation of change in clinical practice 2005, Butterworth-Heinemann, [2004]. 1st ed.
11. Peake S.T.C., Tee C.J., Landy J., Arebi N. Vaccination against opportunistic infections in patients with inflammatory bowel disease on immunomodulator therapy. J Crohns Colitis 2012, P371.
12. Watkins C., Harvey I., Langley C., Gray S., Faulkner A. General practitioners' use of guidelines in the consultation and their attitudes to them. Br J Gen Pract 1999, 49:11-15.
13. Tan M., Holbury R.H., Lange K., Andrews J.M. General practitioners' knowledge of and attitudes to inflammatory bowel disease. Int Med J 2012, 42(7):801-807.
14. Kay S., Frable W.J., Hume D.M. Cervical dysplasia and cancer developing in women on immunosuppressive therapy for renal transplantation. Cancer 1970, 26(5):1048-1052.